NewAmsterdam Pharma (NAMS) Earnings (2023 - 2026)
NewAmsterdam Pharma (NAMS) earnings from Mar 31, 2023 to Mar 31, 2026. The TTM NewAmsterdam Pharma (NAMS) earnings is -$213M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
NewAmsterdam Pharma (NAMS) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +13.53% |
| 3 Years TTM | +71.71% |
| All Time TTM | -3.56% |
Annual Earnings change of NewAmsterdam Pharma (NAMS)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$48M | -76.23% |
| 2025 | -$204M | -15.64% |
| 2024 | -$242M | +36.54% |
| 2023 | -$177M | +221075.00% |
| 2022 | -$80K | +166.67% |
| 2021 | -$30K | +200.00% |
| 2020 | -$10K | N/A |